LIVE

Serial Number

97655075

Owner

Nobelpharma Co., Ltd.

Attorney

LEIGH ANN LINDQUIST

First Use Date

Aug 31, 2022

Filing Date

Oct 31, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

NOBELPHARMA CONNECT Trademark

Serial Number: 97655075 • Registration: 7302992

NOBELPHARMA CONNECT is a trademark filed by Nobelpharma Co., Ltd. on October 31, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently registered and active.

Trademark Classes

Class 36 - Insurance & Financial

Insurance; financial affairs; monetary affairs; real estate affairs

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

Nobelpharma Co., Ltd. (14 trademarks)

12-10 Nihonbashi-kobunacho
Chuo-Ku, Tokyo 103-0024 , JP

Entity Type: 03

Legal Representation

Attorney of Record

LEIGH ANN LINDQUIST

4,514 trademarks filed View all →

Correspondence Address

LEIGH ANN LINDQUIST SUGHRUE MION, PLLC

2000 PENNSYLVANIA AVENUE NW

SUITE 9000

WASHINGTON

DC 20006

Trademark Details

Filing Date

October 31, 2022

Registration Date

February 13, 2024

First Use Anywhere

August 31, 2022

First Use in Commerce

August 31, 2022

Published for Opposition

November 28, 2023

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 13, 2024 NRCC

REGISTERED-PRINCIPAL REGISTER

Feb 13, 2024 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 28, 2023 NPUB

PUBLISHED FOR OPPOSITION

Nov 28, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 8, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 24, 2023 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 20, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 20, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 20, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Aug 31, 2023 GNRN

NON-FINAL ACTION E-MAILED

Aug 31, 2023 GNRT

NON-FINAL ACTION WRITTEN

Aug 31, 2023 CNRT

ASSIGNED TO EXAMINER

Aug 15, 2023 DOCK

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

Jan 23, 2023 AMPX

ASSIGNED TO LIE

Jan 21, 2023 ALIE

TEAS VOLUNTARY AMENDMENT RECEIVED

Nov 21, 2022 PARI

NOTICE OF DESIGN SEARCH CODE E-MAILED

Nov 17, 2022 MDSM

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 16, 2022 NWOS

NEW APPLICATION ENTERED

Nov 3, 2022 NWAP

Related Trademarks

More from this Owner

MELARHYTHMIN

FACE FORWARD

NOBELPHARMA CONNECT

More in Same Class

QUANTIVE